Immediate Impact
56 standout
Citing Papers
Traditional Chinese medicine in lung cancer treatment
2025 Standout
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Works of Ludovic Doucet being referenced
KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation.
2024
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ludovic Doucet | 158 | 170 | 66 | 71 | 37 | 295 | |
| Tomohiro Suzumura | 160 | 213 | 44 | 81 | 36 | 334 | |
| Elisa Bertoli | 164 | 190 | 76 | 73 | 32 | 321 | |
| Francesco Cortiula | 186 | 157 | 40 | 48 | 38 | 295 | |
| Sugganth Daniel | 191 | 95 | 69 | 61 | 26 | 301 | |
| Davide Adriano Santeufemia | 134 | 121 | 57 | 76 | 35 | 326 | |
| Filippo Pagani | 188 | 143 | 68 | 52 | 26 | 277 | |
| Xian Zhang | 117 | 175 | 73 | 108 | 33 | 312 | |
| Yun Zhang | 136 | 94 | 76 | 58 | 21 | 257 | |
| Miguel J. Sotelo | 210 | 96 | 104 | 59 | 34 | 314 | |
| Esther Uña Cidón | 137 | 99 | 62 | 97 | 23 | 301 |
All Works
Login with ORCID to disown or claim papers
Loading papers...